Marek Trneny, MD, PhD1, Michael Rieger2*, Anders Osterborg, MD, PhD3, Ruth Pettengel4*, Darrell J White, MD5, Devinder Gill, MB, FRCPath, FRACP, FRCPA6, Jan Walewski, MD7*, Evelyn Kuhnt8*, Markus Loeffler, Prof.9*, Michael Pfreundschuh, MD, PhD10 and Anthony D. Ho, M.D., Ph.D.11*
1First Dept. of Medicine, Charles Univ. General Hosp., Prague, Czech Republic
2Departement of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
3Deptartment of Hematology, Karolinska Hospital, Stockholm, Sweden
4Haematology, St Georges Hospital, London
5Dalhousie University, Queen Elizabeth II Health Sciences Ctr., Halifax, NS, Canada
6Dept. of Haematology,Pathology Qld, Princess Alexandra Hospital, Brisbane, Australia
7Central Oncology Institute Nowotworow Ukladu Chlonnego Hospital, Warsaw, Poland
8Coordination Centre for Clinical trials Leipzig, University of Leipzig, Leipzig, Germany
9Institute of Medical Informatics, Statistics and Epidemiology, Leipzig, Germany
10Klinik f. Innere Medizin I, Homburg, Saar, Germany
11Department of Medicine V, University of Heidelberg, Heidelberg, Germany